Riskpilot← Back to searchSign inGet full accessSTIM AS
ASActiveOrg 964873755Storeidøya 60, 8370 LeknesWholesale of pharmaceutical and medical goods · NACE 4646Est. 199264 employees
Revenue 2024
NOK 1,7B
+25% vs 2023
EBITDA margin
7.2%
+210% vs 2023
Equity ratio
45.9%
Financial strength
Net profit 2024
NOK 93,3M
+235% vs 2023
| Revenue | NOK 1,7B | +25% |
| EBITDA | NOK 121,6M | +210% |
| Net profit | NOK 93,3M | +235% |
| Total assets | NOK 531,9M | +93% |
| Equity | NOK 243,9M | +1073% |
| Employees | 64 | — |
Legal name
STIM AS
Org number
964873755
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
30. august 1992
Share capital
NOK 82 400
Employees
64 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder hver for seg.
Company purpose
Salg av vaksiner, medisin og utstyr til oppdretts- og landbruksnæringen, samt virksomhet som står i forbindelse hermed.
Address
Storeidøya 60, 8370 Leknes
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 318 043 | 289 174 | 340 850 | 356 233 | 400 052 | 394 521 | 520 053 | 604 361 | 600 891 | 627 751 | 651 341 | 929 999 | 644 084 | 908 462 | 1 035 249 | 1 361 468 | 1 698 020 |
| Staff expenses | −2 560 | −542 | −2 088 | −3 966 | −4 086 | −4 901 | −13 553 | −13 713 | −17 507 | −18 365 | −18 556 | −40 895 | −39 415 | −41 638 | −46 986 | −50 529 | −47 587 |
| EBITDA | 14 879 | 17 760 | 20 150 | 14 565 | 23 296 | 19 132 | 36 456 | 56 235 | 41 172 | 60 215 | 56 199 | 54 434 | 19 105 | 24 866 | 52 987 | 39 210 | 121 601 |
| Depreciation & amort. | −337 | −502 | −495 | −690 | −991 | −724 | −1 740 | −1 747 | −1 830 | −2 331 | −2 685 | −3 458 | −1 861 | −1 861 | −2 029 | −2 273 | −2 309 |
| EBIT | 14 543 | 17 259 | 19 655 | 13 875 | 22 305 | 18 408 | 34 716 | 54 488 | 39 342 | 57 884 | 53 513 | 50 975 | 17 244 | 23 006 | 50 957 | 36 937 | 119 293 |
| Net financials | 576 | −379 | 4 728 | −105 | −1 091 | 702 | −967 | 5 098 | −831 | 6 865 | 26 413 | 1 252 | 604 | −1 683 | −1 809 | −1 055 | 346 |
| Profit before tax | 15 119 | 16 880 | 24 383 | 13 771 | 21 214 | 19 110 | 33 749 | 59 586 | 38 511 | 64 749 | 79 926 | 52 227 | 17 848 | 21 322 | 49 149 | 35 882 | 119 639 |
| Tax | 4 258 | 4 773 | 5 413 | 3 878 | 4 551 | 5 401 | 9 288 | 14 309 | 9 741 | 13 694 | 12 384 | 11 435 | 3 677 | 4 760 | 10 778 | 8 036 | 26 344 |
| Net profit | 10 861 | 12 106 | 18 970 | 9 893 | 16 663 | 13 709 | 24 461 | 45 278 | 28 770 | 51 055 | 67 543 | 40 792 | 14 171 | 16 562 | 38 371 | 27 846 | 93 294 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 65 376 | 91 993 | 80 401 | 70 665 | 102 833 | 95 600 | 177 972 | 209 222 | 220 780 | 191 041 | 222 679 | 278 388 | 217 023 | 265 323 | 326 626 | 275 927 | 531 878 |
| Equity | 7 451 | 9 199 | 15 917 | 15 897 | 11 014 | 9 443 | 18 036 | 46 285 | 52 531 | 22 306 | 33 319 | 33 656 | 29 676 | 31 140 | 45 943 | 20 790 | 243 884 |
| Long-term debt | 0 | 0 | 0 | 0 | 3 229 | 25 854 | 30 307 | 7 115 | 5 318 | 4 483 | 7 393 | 79 101 | 70 823 | 45 174 | 41 619 | 35 109 | 4 |
| Short-term debt | 57 925 | 82 794 | 64 484 | 51 239 | 88 590 | 60 302 | 129 629 | 155 822 | 162 931 | 164 252 | 181 967 | 165 382 | 116 524 | 189 010 | 239 063 | 220 029 | 287 991 |
| Total debt | 57 925 | 82 794 | 64 484 | 54 768 | 91 819 | 86 157 | 159 935 | 162 936 | 168 249 | 168 735 | 189 360 | 244 483 | 187 347 | 234 183 | 280 682 | 255 138 | 287 994 |
EBITDA margin
7.2%
This company
15.8%
Market median
-54% vs market
20082024
Equity ratio
45.9%
This company
38.2%
Market median
+20% vs market
20082024
Return on equity
38.3%
This company
18.4%
Market median
+108% vs market
20082024
Net profit margin
5.5%
This company
8.1%
Market median
-32% vs market
20082024
Asset turnover
3.19×
This company
1.12×
Market median
+185% vs market
20082024
Debt / equity
1.18×
This company
0.62×
Market median
-90% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JR Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
CE Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2014 | — | — | |
| Chairman | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Nordly Holding As | Company | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Pitancia As
STIM AS Board members of STIM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jim Roger Nordly | Chief Executive Officer | 0 companies |
| Carl Erik Arnesen | Chief Executive Officer | 0 companies |
| Martin Gjølme | Board of Directors | 0 companies |
| Paal Christian Krüger | Board of Directors | 0 companies |
| Hannah Gunvor Jacobsen | Chairman | 0 companies |